SEC Filing: Form 8-K
Current report
VYNE TherapeuticsRooted in Innovation
VYNE Therapeutics
Current report
Quarterly report [Sections 13 or 15(d)]
Statement of changes in beneficial ownership of securities
Statement of changes in beneficial ownership of securities
Statement of changes in beneficial ownership of securities
Statement of changes in beneficial ownership of securities